Kessler Foundation Selects Ekso Bionics GT™ For Pilot Study On Robotics In Mobility

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

RICHMOND, Calif., April 10, 2014 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (OTCQB:EKSO), a robotic exoskeleton company, announced today that Kessler Foundation, a global leader in rehabilitation research, has purchased a second exoskeleton, the Ekso GT, to be used in a new study examining the effectiveness of wearable robots for neuro-rehabilitation and gait training. Kessler Foundation is one of the first organizations to integrate the most recent evolution of this technology, which will be used solely to study its efficacy for patients with hemiparesis who are less than three months post-stroke.

Help employers find you! Check out all the jobs and post your resume.
MORE ON THIS TOPIC